MEDICAL RESOURCES

Abituzumab (pan-αv integrin inhibiting mAb)

Status

• Abituzumab is an investigational pan-αv integrin inhibiting monoclonal antibody currently being investigated in clinical trials for the treatment of metastatic colorectal cancer.

Action SVG
Action SVG
Action SVG
eMedI Chat
Close
After your vist, Please answer a few questions to help us improve?
Survey
Please click on icon to provide survey...